R J Hayashi
Overview
Explore the profile of R J Hayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Satwani P, Ahn K, Carreras J, Abdel-Azim H, Cairo M, Cashen A, et al.
Bone Marrow Transplant
. 2015 Aug;
50(11):1416-23.
PMID: 26237164
Autologous hematopoietic cell transplantation (AutoHCT) is a potentially curative treatment modality for relapsed/refractory Hodgkin lymphoma (HL). However, no large studies have evaluated pretransplant factors predictive of outcomes of AutoHCT in...
2.
Inamoto Y, Shah N, Savani B, Shaw B, Abraham A, Ahmed I, et al.
Bone Marrow Transplant
. 2015 Mar;
50(8):1013-23.
PMID: 25822223
Hematopoietic stem cell transplant (HCT) recipients have a substantial risk of developing secondary solid cancers, particularly beyond 5 years after HCT and without reaching a plateau overtime. A working group...
3.
Danner-Koptik K, Majhail N, Brazauskas R, Wang Z, Buchbinder D, Cahn J, et al.
Bone Marrow Transplant
. 2012 Sep;
48(3):363-8.
PMID: 22964594
Childhood autologous hematopoietic cell transplant (auto-HCT) survivors can be at risk for secondary malignant neoplasms (SMNs). We assembled a cohort of 1487 pediatric auto-HCT recipients to investigate the incidence and...
4.
Gross T, Orjuela M, Perkins S, Park J, Lynch J, Cairo M, et al.
Am J Transplant
. 2012 Aug;
12(11):3069-75.
PMID: 22883417
Optimal therapy for posttransplant lymphoproliferative disease (PTLD) remains problematic. A phase II trial adding rituximab to a low-dose cyclophosphamide and prednisone regimen was conducted for pediatric patients with Epstein-Barr virus...
5.
Baker K, Filipovich A, Gross T, Grossman W, Hale G, Hayashi R, et al.
Bone Marrow Transplant
. 2008 May;
42(3):175-80.
PMID: 18454181
We report outcomes after unrelated donor hematopoietic cell transplantation (HCT) for 91 patients with hemophagocytic lymphohistiocytosis (HLH) transplanted in the US in 1989-2005. Fifty-one percent were <1 year at HCT...
6.
Pulsipher M, Levine J, Hayashi R, Chan K, Anderson P, Duerst R, et al.
Bone Marrow Transplant
. 2004 Dec;
35(4):361-7.
PMID: 15608659
The use of peripheral blood stem cells (PBSC) for allogeneic transplants in adults has greatly increased. This trend is reflected in pediatrics, where healthy children increasingly are donating PBSC or...
7.
Shenoy S, Grossman W, DiPersio J, Yu L, Wilson D, Barnes Y, et al.
Bone Marrow Transplant
. 2004 Dec;
35(4):345-52.
PMID: 15592491
Bone marrow transplantation (BMT) benefits nonmalignant diseases but is limited by regimen-related toxicity, graft-versus-host disease (GVHD), donor availability, and graft rejection (GR). To overcome some of these barriers, we developed...
8.
Gauvain K, McKinstry R, Mukherjee P, Perry A, Neil J, Kaufman B, et al.
AJR Am J Roentgenol
. 2001 Jul;
177(2):449-54.
PMID: 11461881
Objective: MR imaging of central nervous system (CNS) malignancies falls short of a definitive evaluation. Tissue diagnosis remains the gold standard. Diffusion-tensor MR imaging measures the apparent diffusion coefficient and...
9.
Khoury H, Kashyap A, Adkins D, BROWN R, Miller G, Vij R, et al.
Bone Marrow Transplant
. 2001 Jul;
27(10):1059-64.
PMID: 11438821
Acute graft-versus-host disease (aGVHD) is a major cause of mortality after allogeneic stem cell transplantation. Although initial treatment with corticosteroids is effective in the majority of patients, 30--60% develop steroid...
10.
Hayashi R, Kraus M, Patel A, Canter C, Cohen A, Hmiel P, et al.
J Pediatr Hematol Oncol
. 2001 Feb;
23(1):14-8.
PMID: 11196263
Purpose: To determine whether the morphologic features of posttransplant lymphoproliferative disease (PTLD) correlated to a response to therapy. Patients And Methods: We reviewed our experience with PTLD in the pediatric...